Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Jie Chen, Xuejie Chen, Ying Xie, Yuhao Sun, Xiaoyan Wang & Therese Hesketh. (2021) Irritable bowel syndrome and migraine: evidence from Mendelian randomization analysis in the UK Biobank. Expert Review of Gastroenterology & Hepatology 15:10, pages 1233-1239.
Read now
Read now
Herman Depypere, Christopher Lademacher, Emad Siddiqui & Graeme L Fraser. (2021) Fezolinetant in the treatment of vasomotor symptoms associated with menopause. Expert Opinion on Investigational Drugs 30:7, pages 681-694.
Read now
Read now
S Kongthong, A Phumyen & J Meephansan. (2019) Effect of narrowband ultraviolet B therapy on serum levels of CD26/dipeptidyl-peptidase IV and truncated forms of substance P in psoriasis patients with pruritus. Clinical, Cosmetic and Investigational Dermatology 12, pages 597-604.
Read now
Read now
Nicole M. Ryan, Anne E. Vertigan & Surinder S. Birring. (2018) An update and systematic review on drug therapies for the treatment of refractory chronic cough. Expert Opinion on Pharmacotherapy 19:7, pages 687-711.
Read now
Read now
Shih-Chung Huang & Vijaya L Korlipara. (2010) Neurokinin-1 receptor antagonists: a comprehensive patent survey. Expert Opinion on Therapeutic Patents 20:8, pages 1019-1045.
Read now
Read now
Laura Quartara, Maria Altamura, Stefano Evangelista & Carlo A Maggi. (2009) Tachykinin receptor antagonists in clinical trials. Expert Opinion on Investigational Drugs 18:12, pages 1843-1864.
Read now
Read now
Jeffrey S Albert & William Potts. (2006) Neurokinin-3 receptor antagonists in schizophrenia. Expert Opinion on Therapeutic Patents 16:7, pages 925-937.
Read now
Read now
Articles from other publishers (50)
Chien-Liang Fang, Debakshee Goswami, Chia-Hua Kuo, Cecilia Hsuan Day, Mei-Yi Lin, Tsung-Jung Ho, Liang-Yo Yang, Dennis Jine-Yuan Hsieh, Tzu-Kai Lin & Chih-Yang Huang. (2022) Angelica dahurica attenuates melanogenesis in B16F0 cells by repressing Wnt/β-catenin signaling. Molecular & Cellular Toxicology 19:1, pages 135-143.
Crossref
Crossref
Renata Virgínia Cavalcanti Santos, Eudes Gustavo Constantino Cunha, Gabriela Souto Vieira de Mello, José Ângelo Rizzo, Jamerson Ferreira de Oliveira, Maria do Carmo Alves de Lima, Ivan da Rocha Pitta, Maira Galdino da Rocha Pitta & Moacyr Jesus Barreto de Melo Rêgo. (2021) New Oxazolidines Inhibit the Secretion of IFN-γ and IL-17 by PBMCS from Moderate to Severe Asthmatic Patients. Medicinal Chemistry 17:3, pages 289-297.
Crossref
Crossref
Eunsoo Won, Kyu-Man Han, Aram Kim, Min-Soo Lee, Yong-Ku Kim, Hun Soo Chang & Byung-Joo Ham. (2019) The associations of TAC1 gene polymorphisms with major depressive disorder. Molecular & Cellular Toxicology 15:2, pages 129-136.
Crossref
Crossref
Jeffrey S. Barrett, Sergei Spitsin, Ganesh Moorthy, Kyle Barrett, Kate Baker, Andrew Lackner, Florin Tulic, Angela Winters, Dwight L. Evans & Steven D. Douglas. (2016) Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIV. Journal of Translational Medicine 14:1.
Crossref
Crossref
Jia Zhou, Jingjing Ling, Huizhu Song, Bei Lv, Lei Wang, Jing Shang, Yong Wang, Chunyan Chang, Fengfeng Ping & Jun Qian. (2016) Neurokinin-1 receptor is a novel positive regulator of Wnt/β-catenin signaling in melanogenesis. Oncotarget 7:49, pages 81268-81280.
Crossref
Crossref
Mu Seob Park, Hyun Jong Lee, Yun Kyu Lee, Mu Ryeo Kim, Hae Jin Park & Jae Soo Kim. (2016) Analgesic Effect of Pharmacopuncture on Formalin-Induced Pain in Rats. The Acupuncture 33:2, pages 97-108.
Crossref
Crossref
Andrew C. Flick, Hong X. Ding, Carolyn A. Leverett, Robert E. KyneJr.Jr., Kevin K.-C. Liu, Sarah J. Fink & Christopher J. O’Donnell. (2016) Synthetic approaches to the 2014 new drugs. Bioorganic & Medicinal Chemistry 24:9, pages 1937-1980.
Crossref
Crossref
Yu Zhou, Jiang Wang, Zhanni Gu, Shuni Wang, Wei Zhu, José Luis Aceña, Vadim A. Soloshonok, Kunisuke Izawa & Hong Liu. (2016) Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas. Chemical Reviews 116:2, pages 422-518.
Crossref
Crossref
Tomo Hayase, Shunsuke Tachibana & Michiaki Yamakage. (2016) Effect of sevoflurane anesthesia on the comprehensive mRNA expression profile of the mouse hippocampus. Medical Gas Research 6:2, pages 70.
Crossref
Crossref
Leonardo Lorente, María M Martín, Teresa Almeida, Mariano Hernández, Luis Ramos, Mónica Argueso, Juan J Cáceres, Jordi Solé-Violán & Alejandro Jiménez. (2015) Serum substance P levels are associated with severity and mortality in patients with severe traumatic brain injury. Critical Care 19:1.
Crossref
Crossref
Charles C. Horn. 2014. Pain Genetics. Pain Genetics
115
130
.
Charles C. Horn, William J. Wallisch, Gregg E. Homanics & John P. Williams. (2014) Pathophysiological and neurochemical mechanisms of postoperative nausea and vomiting. European Journal of Pharmacology 722, pages 55-66.
Crossref
Crossref
Stephen Hanessian, Vincent Babonneau, Nicolas Boyer, Clotilde Mannoury la Cour, Mark J. Millan & Guillaume De Nanteuil. (2014) Design and synthesis of potential dual NK1/NK3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 24:2, pages 510-514.
Crossref
Crossref
Jennifer Victoria Bodkin & Elizabeth Soares Fernandes. (2013)
TRPV1
and
SP
: key elements for sepsis outcome?
. British Journal of Pharmacology 170:7, pages 1279-1292.
Crossref
Crossref
Dong Xiao, Cheng Wang, Hon-Chung Tsui, Anandan Palani, Robert Aslanian & Alexei V. Buevich. (2013) Conformation of gem-disubstituted alkylarylpiperidines and their implication in design and synthesis of a conformationally-rigidified NK1 antagonist. Tetrahedron Letters 54:46, pages 6199-6203.
Crossref
Crossref
Full-Young Chang & Ching-Liang Lu. (2013) Irritable Bowel Syndrome and Migraine: Bystanders or Partners?. Journal of Neurogastroenterology and Motility 19:3, pages 301-311.
Crossref
Crossref
Ruth A. Duffy, Cynthia Morgan, Robert Naylor, Guy A. Higgins, Geoffrey B. Varty, Jean E. Lachowicz & Eric M. Parker. (2012) Rolapitant (SCH 619734): A potent, selective and orally active neurokinin NK1 receptor antagonist with centrally-mediated antiemetic effects in ferrets. Pharmacology Biochemistry and Behavior 102:1, pages 95-100.
Crossref
Crossref
Lei Sun & Richard D Ye. (2012) Role of G protein-coupled receptors in inflammation. Acta Pharmacologica Sinica 33:3, pages 342-350.
Crossref
Crossref
Paola Sacerdote & Luca Levrini. (2012) Peripheral Mechanisms of Dental Pain: The Role of Substance P. Mediators of Inflammation 2012, pages 1-6.
Crossref
Crossref
Junya Shirai, Takeshi Yoshikawa, Masayuki Yamashita, Yasuharu Yamamoto, Makiko Kawamoto, Naoki Tarui, Izumi Kamo, Tadatoshi Hashimoto & Yoshinori Ikeura. (2011) Design, structure–activity relationship, and highly efficient asymmetric synthesis of 3-phenyl-4-benzylaminopiperidine derivatives as novel neurokinin-1 receptor antagonists. Bioorganic & Medicinal Chemistry 19:21, pages 6430-6446.
Crossref
Crossref
Robert L. Gannon, Elizabeth Lungwitz, Natalia Batista, Ian Hester, Christina Huntley, Alyssa Peacock, Philippe Delagrange & Mark J. Millan. (2011) The benzodiazepine diazepam demonstrates the usefulness of Syrian hamsters as a model for anxiety testing: Evaluation of other classes of anxiolytics in comparison to diazepam. Behavioural Brain Research 218:1, pages 8-14.
Crossref
Crossref
Dong Xiao, Cheng Wang, Anandan Palani, Hon-Chung Tsui, Gregory Reichard, Sunil Paliwal, Neng-Yang Shih, Robert Aslanian, Ruth Duffy, Jean Lachowicz, Geoffrey Varty, Cynthia Morgan, Fei Liu & Amin Nomeir. (2010) Discovery of a series of potent, orally active α,α-disubstituted piperidine NK1 antagonists. Bioorganic & Medicinal Chemistry Letters 20:21, pages 6313-6315.
Crossref
Crossref
Anja Sipka, Kathrin Langner, Hans-Martin Seyfert & Hans-Joachim Schuberth. (2010) Substance P alters the in vitro LPS responsiveness of bovine monocytes and blood-derived macrophages. Veterinary Immunology and Immunopathology 136:3-4, pages 219-226.
Crossref
Crossref
Hong-Yuan Zhu, Andri-K Riau, V A Barathi, Jaime Chew & Roger W Beuerman. (2010) Expression of Neural Receptors in Mouse Meibomian Gland. Cornea 29:7, pages 794-801.
Crossref
Crossref
Jordanka Kirkova, Declan WalshLisa Rybicki, Mellar P Davis, Aynur Aktas, Tao Jin & Jade Homsi. (2009) Symptom severity and distress in advanced cancer. Palliative Medicine 24:3, pages 330-339.
Crossref
Crossref
Jianming Bao, Huagang Lu, Gregori J. Morriello, Emma J. Carlson, Alan Wheeldon, Gary G. Chicchi, Marc M. Kurtz, Kwei-Lan C. Tsao, Song Zheng, Xinchun Tong, Sander G. Mills & Robert J. DeVita. (2010) Tetrahydroindolizinone NK1 antagonists. Bioorganic & Medicinal Chemistry Letters 20:7, pages 2354-2358.
Crossref
Crossref
Fabio M. Sabbatini, Romano Di Fabio, Cristiana Griffante, Giorgio Pentassuglia, Laura Zonzini, Sergio Melotto, Giuseppe Alvaro, Anna M. Capelli, Lara Pippo, Elisabetta Perdona’, Yves St. Denis, Silvano Costa & Mauro Corsi. (2010) Synthesis and pharmacological characterization of constrained analogues of Vestipitant as in vitro potent and orally active NK1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 20:2, pages 623-627.
Crossref
Crossref
Jonathan M. Gibbins. (2009) Tweaking the gain on platelet regulation: The tachykinin connection. Atherosclerosis 206:1, pages 1-7.
Crossref
Crossref
Ranjinidevi Ambalavanar & Dean Dessem. 2009. Peripheral Receptor Targets for Analgesia. Peripheral Receptor Targets for Analgesia
373
396
.
R. Ambalavanar & D. Dessem. (2009) Emerging Peripheral Receptor Targets for Deep-tissue Craniofacial Pain Therapies. Journal of Dental Research 88:3, pages 201-211.
Crossref
Crossref
Mauricette Brocco, Anne Dekeyne, Clotilde Mannoury la Cour, Manuelle Touzard, Sylvie Girardon, Sylvie Veiga, Guillaume de Nanteuil, Trynke R. deJong, Berend Olivier & Mark J. Millan. (2008) Cellular and behavioural profile of the novel, selective neurokinin1 receptor antagonist, vestipitant: A comparison to other agents. European Neuropsychopharmacology 18:10, pages 729-750.
Crossref
Crossref
Sunil Paliwal, Gregory A. Reichard, Sapna Shah, Michelle Laci Wrobleski, Cheng Wang, Carmine Stengone, Hon-Chung Tsui, Dong Xiao, Ruth A. Duffy, Jean E. Lachowicz, Amin A. Nomeir, Geoffrey B. Varty & Neng-Yang Shih. (2008) Discovery of a novel, potent and orally active series of γ-lactams as selective NK1 antagonists. Bioorganic & Medicinal Chemistry Letters 18:14, pages 4168-4171.
Crossref
Crossref
Iordanes Karagiannides, Daniel Torres, Yu–Hua Tseng, Collin Bowe, Eugenia Carvalho, Daniel Espinoza, Charalabos Pothoulakis & Efi Kokkotou. (2008) Substance P as a Novel Anti-obesity Target. Gastroenterology 134:3, pages 747-755.e1.
Crossref
Crossref
Monika Sundqvist, Elin Kristensson, Rebecka Adolfsson, Agnes Leffler, Ingela Ahlstedt, Susanna Engberg, Tomas Drmota, Kalle Sigfridsson, Rainer Jussila, Jennie de Verdier, Anna Novén, Anders Johansson, Ingrid Påhlman, Bengt von Mentzer & Erik Lindström. (2007) Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists. European Journal of Pharmacology 577:1-3, pages 78-86.
Crossref
Crossref
Ulises Meza, Ashish Thapliyal, Roger A. Bannister & Brett A. Adams. (2007)
Neurokinin 1 Receptors Trigger Overlapping Stimulation and Inhibition of Ca
V
2.3 (R-Type) Calcium Channels
. Molecular Pharmacology 71:1, pages 284-293.
Crossref
Crossref
Susanna Engberg, Ingela Ahlstedt, Agnes Leffler, Erik Lindström, Elin Kristensson, Arne Svensson, Ingrid Påhlman, Anders Johansson, Tomas Drmota & Bengt von Mentzer. (2007) Molecular cloning, mutations and effects of NK1 receptor antagonists reveal the human-like pharmacology of gerbil NK1 receptors. Biochemical Pharmacology 73:2, pages 259-269.
Crossref
Crossref
Jacob N Ablin, Hagit Cohen & Dan Buskila. (2006) Mechanisms of Disease: genetics of fibromyalgia. Nature Clinical Practice Rheumatology 2:12, pages 671-678.
Crossref
Crossref
Jay C. Elliott, Alison F. Wagner & Donald T. Lysle. (2006) Neurokinin 1 receptor signaling mediates sex differences in μ and κ opioid-induced enhancement of contact hypersensitivity. Journal of Neuroimmunology 181:1-2, pages 100-105.
Crossref
Crossref
Peter J. HarringtonDave JohnstonHenk MoorlagJim-Wah WongL. Mark HodgesLes HarrisGerald K. McEwenBlair Smallwood. (2006) Research and Development of an Efficient Process for the Construction of the 2,4,5-Substituted Pyridines of NK-1 Receptor Antagonists. Organic Process Research & Development 10:6, pages 1157-1166.
Crossref
Crossref
Michelle Laci Wrobleski, Gregory A. Reichard, Sunil Paliwal, Sapna Shah, Hon-Chung Tsui, Ruth A. Duffy, Jean E. Lachowicz, Cynthia A. Morgan, Geoffrey B. Varty & Neng-Yang Shih. (2006) Cyclobutane derivatives as potent NK1 selective antagonists. Bioorganic & Medicinal Chemistry Letters 16:14, pages 3859-3863.
Crossref
Crossref
David Borsook, Lino Becerra & Richard Hargreaves. (2006) A role for fMRI in optimizing CNS drug development. Nature Reviews Drug Discovery 5:5, pages 411-425.
Crossref
Crossref
Anandan Palani & Jayaram R. Tagat. (2006) Discovery and Development of Small-Molecule Chemokine Coreceptor CCR5 Antagonists. Journal of Medicinal Chemistry 49:10, pages 2851-2857.
Crossref
Crossref
Esther M. Sternberg. (2006) Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nature Reviews Immunology 6:4, pages 318-328.
Crossref
Crossref
Fabienne Hoffmann-Emery, Hans Hilpert, Michelangelo Scalone & Pius Waldmeier. (2006)
Efficient Synthesis of Novel NK
1
Receptor Antagonists: Selective 1,4-Addition of Grignard Reagents to 6-Chloronicotinic Acid Derivatives
. The Journal of Organic Chemistry 71:5, pages 2000-2008.
Crossref
Crossref
Torsten Hoffmann, Michael Bös, Heinz Stadler, Patrick Schnider, Walter Hunkeler, Thierry Godel, Guido Galley, Theresa M. Ballard, Guy A. Higgins, Sonia M. Poli & Andrew J. Sleight. (2006) Design and synthesis of a novel, achiral class of highly potent and selective, orally active neurokinin-1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters 16:5, pages 1362-1365.
Crossref
Crossref
Ho-Jane Shue, Xiao Chen, John H. Schwerdt, Sunil Paliwal, David J. Blythin, Ling Lin, Danlin Gu, Cheng Wang, Gregory A. Reichard, Hongwu Wang, John J. Piwinski, Ruth A. Duffy, Jean E. Lachowicz, Vicki L. Coffin, Amin A. Nomeir, Cynthia A. Morgan, Geoffrey B. Varty & Neng-Yang Shih. (2006) Cyclic urea derivatives as potent NK1 selective antagonists. Part II: Effects of fluoro and benzylic methyl substitutions. Bioorganic & Medicinal Chemistry Letters 16:4, pages 1065-1069.
Crossref
Crossref
Robert L. Gannon & Mark J. Millan. (2005) The selective tachykinin neurokinin 1 (NK1) receptor antagonist, GR 205,171, stereospecifically inhibits light-induced phase advances of hamster circadian activity rhythms. European Journal of Pharmacology 527:1-3, pages 86-93.
Crossref
Crossref
Ho-Jane Shue, Xiao Chen, Neng-Yang Shih, David J. Blythin, Sunil Paliwal, Ling Lin, Danlin Gu, John H. Schwerdt, Sapna Shah, Gregory A. Reichard, John J. Piwinski, Ruth A. Duffy, Jean E. Lachowicz, Vicki L. Coffin, Fei Liu, Amin A. Nomeir, Cynthia A. Morgan & Geoffrey B. Varty. (2005) Cyclic urea derivatives as potent NK1 selective antagonists. Bioorganic & Medicinal Chemistry Letters 15:17, pages 3896-3899.
Crossref
Crossref
Mathias Hallberg, Anna M.S. Kindlundh & Fred Nyberg. (2005) The impact of chronic nandrolone decanoate administration on the NK1 receptor density in rat brain as determined by autoradiography. Peptides 26:7, pages 1228-1234.
Crossref
Crossref
Lu Liu, Michael Murray, J. Michael Conlon & Elizabeth Burcher. (2005) Quantitative structure–activity analyses of bufokinin and other tachykinins at bufokinin (bNK1) receptors of the small intestine of the cane toad, Bufo marinus. Biochemical Pharmacology 69:2, pages 329-338.
Crossref
Crossref